Figure 6.

miR‐130b mediates cisplatin resistance in vivo. (A) miR‐130b expression in tumour was detected by real‐time PCR. (B) Mice were treated with cisplatin or buffer. Tumour volume was calculated after treatment (n = 6 in each group). (C) Paraffin‐embedded sections of tumour tissues from mice were analysed by TUNEL staining. (D) Mice were treated with cisplatin, miR‐130b, or the combination. Tumour volume was calculated after treatment (n = 6 in each group). (E) Paraffin‐embedded sections of tumour tissues from mice were analysed by TUNEL staining. Results in (A), (B), and (D) were expressed as means ± SD of 3 independent experiments